These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 16337105)
1. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. Murakami Y; Akahoshi T; Hayashi I; Endo H; Hashimoto A; Kono S; Kondo H; Kawai S; Inoue M; Kitasato H Arthritis Rheum; 2003 Oct; 48(10):2931-41. PubMed ID: 14558100 [TBL] [Abstract][Full Text] [Related]
3. Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. Ando M; Murakami Y; Kojima F; Endo H; Kitasato H; Hashimoto A; Kobayashi H; Majima M; Inoue M; Kondo H; Kawai S; Hayashi I Am J Respir Cell Mol Biol; 2003 May; 28(5):582-91. PubMed ID: 12707014 [TBL] [Abstract][Full Text] [Related]
4. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice. Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374 [TBL] [Abstract][Full Text] [Related]
5. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma. Yamamoto T; Takagawa S; Katayama I; Nishioka K Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648 [TBL] [Abstract][Full Text] [Related]
6. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma. Yamamoto T; Nishioka K Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma. Wu MH; Yokozeki H; Takagawa S; Yamamoto T; Satoh T; Kaneda Y; Katayama I; Nishioka K Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301 [TBL] [Abstract][Full Text] [Related]
8. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844 [TBL] [Abstract][Full Text] [Related]
9. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. Hossain MS; Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K Exp Cell Res; 2012 Feb; 318(4):408-15. PubMed ID: 22100987 [TBL] [Abstract][Full Text] [Related]
10. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873 [TBL] [Abstract][Full Text] [Related]
11. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma. Nakamura-Wakatsuki T; Oyama N; Yamamoto T Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586 [TBL] [Abstract][Full Text] [Related]
12. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis. Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of etanercept in bleomycin-induced experimental scleroderma. Koca SS; Isik A; Ozercan IH; Ustundag B; Evren B; Metin K Rheumatology (Oxford); 2008 Feb; 47(2):172-5. PubMed ID: 18174229 [TBL] [Abstract][Full Text] [Related]
14. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529 [TBL] [Abstract][Full Text] [Related]
15. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model. Liu S; Kapoor M; Denton CP; Abraham DJ; Leask A Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619 [TBL] [Abstract][Full Text] [Related]
16. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. Katura T; Moriya T; Nakahata N Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036 [TBL] [Abstract][Full Text] [Related]
17. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. Emi M; Maeyama K Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841 [TBL] [Abstract][Full Text] [Related]
18. Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes. Chowdhury AA; Hossain MS; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K Biochem Biophys Res Commun; 2011 Jul; 411(2):287-92. PubMed ID: 21726533 [TBL] [Abstract][Full Text] [Related]
19. Tumor apoptosis in prostate cancer by PGD(2) and its metabolite 15d-PGJ(2) in murine model. Nakamura M; Tsumura H; Satoh T; Matsumoto K; Maruyama H; Majima M; Kitasato H Biomed Pharmacother; 2013 Feb; 67(1):66-71. PubMed ID: 23206752 [TBL] [Abstract][Full Text] [Related]
20. Positioning prostanoids of the D and J series in the immunopathogenic scheme. Herlong JL; Scott TR Immunol Lett; 2006 Feb; 102(2):121-31. PubMed ID: 16310861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]